Clinical Study
Dose-Dense Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Node-Positive Breast Cancer
Table 2
Incidence of toxicities in treated patients.
| | Toxicities | G2 number (%) | G4 number (%) |
| | Haematological toxicity | | | | Neutropenia | 11 (18.3) | — | | Febrile neutropenia | 1 (1.7) | — | | Anemia | 14 (23.3) | — | | Thrombocytopenia | 3 (5) | — | | Nonhaematological toxicity | | | | Skin-nail disorders | 1 (1.7) | 3 (5) | | Scaling | — | — | | Stomatitis | — | — | | Hand-foot syndrome | — | — | | Erythema | — | — | | Paresis | — | — | | Paresthesia | 2 (3.3) | 7 (11.7) | | Myalgia | 9 (15) | 2 (3.3) | | Arthralgia | 4 (6.7) | 2 (3.3) | | Nausea | 6 (10) | 2 (3.3) | | Vomiting | — | — | | Diarrhea | — | 2 (3.3) | | Fluid retention | 1 (1.7) | — |
| | Any grade 4 event | 9 (15) |
|
|
